| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |